NCT00345956View on ClinicalTrials.gov

To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)

PHASE3CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

March 31, 2007

Conditions
Infections, Rotavirus
Interventions
BIOLOGICAL

Human rotavirus liquid vaccine

Trial Locations (2)

084

GSK Investigational Site, Hanoi

GSK Investigational Site, Nhatrang

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY